All results
1 results
-
INHALE
INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the…
- Ages
- 4 Years - 17 Years
- Sexes
- All